BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33186791)

  • 1. Primary De novo ductal adenocarcinoma of the lacrimal gland.
    Tripathy D; Agarwal S; Biala A; Rath S; Mittal R
    Ann Diagn Pathol; 2021 Feb; 50():151651. PubMed ID: 33186791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case of ductal adenocarcinoma ex pleomorphic adenoma of the lacrimal gland.
    Ishida M; Hotta M; Kushima R; Tsuruoka S; Ohji M; Okabe H
    Rinsho Byori; 2009 Aug; 57(8):746-51. PubMed ID: 19764409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacrimal gland ductal carcinomas: Clinical, Morphological and Genetic characterization and implications for targeted treatment.
    Andreasen S; Grauslund M; Heegaard S
    Acta Ophthalmol; 2017 May; 95(3):299-306. PubMed ID: 27808478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of primary ductal adenocarcinoma of the lacrimal gland: histopathological and immunohistochemical study.
    Kurisu Y; Shibayama Y; Tsuji M; Kurokawa A; Akutagawa H; Egashira Y; Matsuo T; Itabashi T
    Pathol Res Pract; 2005; 201(1):49-53. PubMed ID: 15807311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracapsular High-Grade Ductal Carcinoma In-Situ Ex Pleomorphic Adenoma of the Lacrimal Gland.
    Garakani R; Kersten R; Pekmezci M
    Ophthalmic Plast Reconstr Surg; 2020; 36(1):e1-e3. PubMed ID: 31743286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma of the lacrimal gland: a case report.
    Touil A; El Abbassi S; Echchikhi Y; Maher M; Kebdani T; Benjaafar N
    J Med Case Rep; 2017 Sep; 11(1):257. PubMed ID: 28889800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study.
    Jalaly JB; Sanati S; Chernock RD; Dibe DG; El-Mofty SK
    Head Neck Pathol; 2018 Dec; 12(4):488-492. PubMed ID: 29302899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary ductal adenocarcinoma of the lacrimal gland: A review and report of five cases.
    See TRO; Stålhammar G; Tang T; Manusow JS; Jordan DR; Nerad JA; Kersten RC; Yonkers M; Syed NA; Brownstein S; Grossniklaus HE
    Surv Ophthalmol; 2020; 65(3):371-380. PubMed ID: 31837385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary ductal adenocarcinoma of the lacrimal gland.
    Milman T; Shields JA; Husson M; Marr BP; Shields CL; Eagle RC
    Ophthalmology; 2005 Nov; 112(11):2048-51. PubMed ID: 16271319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary ductal adenocarcinoma of the lacrimal gland, associated with abundant intracytoplasmic lumens containing some eosinophilic hyaline globules: cytological, histological and ultrastructural findings.
    Min KW; Park HK; Kim WY; Kim WS; Lim SD; Han HS; Hwang TS
    Ultrastruct Pathol; 2014 Oct; 38(5):363-6. PubMed ID: 24932904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of PTEN, Androgen Receptor, HER2/neu, Cytokeratin 5/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in Salivary Duct Carcinoma.
    Liang L; Williams MD; Bell D
    Head Neck Pathol; 2019 Dec; 13(4):529-534. PubMed ID: 30390196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial tumors of the lacrimal glands: a clinicopathologic study.
    Paulino AF; Huvos AG
    Ann Diagn Pathol; 1999 Aug; 3(4):199-204. PubMed ID: 10459045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary ductal adenocarcinoma of the lacrimal gland.
    Katz SE; Rootman J; Dolman PJ; White VA; Berean KW
    Ophthalmology; 1996 Jan; 103(1):157-62. PubMed ID: 8628547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GCDFP-15, AR, and Her-2 as biomarkers for primary ductal adenocarcinoma of the lacrimal gland: a Chinese case and literature review.
    Zhu MM; Cui HG; Teng XD
    Onco Targets Ther; 2015; 8():1017-24. PubMed ID: 25999735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
    Matsubayashi S; Yoshihara T
    Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and immunohistochemical behavior of ductal carcinoma of the salivary and lacrimal gland in a Mexican Mestizo population.
    Luna-Ortiz K; Dominguez-Malagon H; Corredor-Alonso GE; Reynoso-Noveron N; Herrera-Ponzanelli C; Luna-Peteuil Z; Zacarias-Ramon LC
    Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):327-333. PubMed ID: 33763743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
    Andreasen S; von Holstein SL; Homøe P; Heegaard S
    Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and immunohistochemical features of primary ductal adenocarcinoma of lacrimal gland: five new cases and review of literature.
    Kubota T; Moritani S; Ichihara S
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2071-6. PubMed ID: 23613093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleomorphic adenocarcinoma of the lacrimal gland with multiple intracranial and spinal metastases.
    Ahn JY; Chang JH; Kim SH; Lee KS
    World J Surg Oncol; 2007 Mar; 5():29. PubMed ID: 17341319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of tyrosine kinase receptor B and brain-derived neurotrophic factor expression in salivary duct carcinoma.
    Kondo Y; Hirabayashi K; Carreras J; Tsukinoki K; Ota Y; Okami K; Nakamura N
    Ann Diagn Pathol; 2021 Feb; 50():151673. PubMed ID: 33248386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.